A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2006
11/30/2006	WO2006127905A2 Portable drug delivery device
11/30/2006	WO2006127879A1 Flexible solid dosage forms and methods of making and using the same
11/30/2006	WO2006127841A2 Multi-reservoir implantable pump with variable flow rate capabilities
11/30/2006	WO2006127748A1 Use of huperzine for disorders
11/30/2006	WO2006127639A2 Process for preparation of isotonic aqueous injection of ropivacaine
11/30/2006	WO2006127508A2 Improved configuration for drug delivery systems
11/30/2006	WO2006127418A1 Scopolamine for the treatment of depression and anxiety
11/30/2006	WO2006127361A2 Lipid construct for delivery of insulin to a mammal
11/30/2006	WO2006127360A2 Lipid construct for delivery of interferon to a mammal
11/30/2006	WO2006127355A2 Oral drug compliance monitoring using radio frequency identification tags
11/30/2006	WO2006127284A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold
11/30/2006	WO2006127121A2 Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
11/30/2006	WO2006127096A2 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
11/30/2006	WO2006127074A1 A delivery system for two or more active components as part of an edible composition
11/30/2006	WO2006127057A1 Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction
11/30/2006	WO2006127053A2 Controlled release oral delivery systems
11/30/2006	WO2006127044A2 Pharmaceutical formulations useful for inhibiting acid secretion
11/30/2006	WO2006126825A1 Composition comprising tetrafluorobenzyl derivatives or salts of thereof for injection
11/30/2006	WO2006126681A1 Pharmaceutical composition
11/30/2006	WO2006126630A1 Method for preparation of aqueous doripenem solution
11/30/2006	WO2006126581A1 Combination drug
11/30/2006	WO2006126561A1 Method of marking composition for oral administration
11/30/2006	WO2006126244A1 Method of producing liposomes containing gas enclosed therein
11/30/2006	WO2006126214A2 Injectable compositions and process for preparation of such compositions
11/30/2006	WO2006126208A2 Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
11/30/2006	WO2006126034A1 Medicated product for local use based on natural materials
11/30/2006	WO2006125978A2 Assay particles
11/30/2006	WO2006125816A1 Oral pharmaceutical formulation for treating a cox-2 mediated condition
11/30/2006	WO2006125811A1 Oral dosage form comprising at least one active principle having a solubility that varies as a function of gastric ph conditions
11/30/2006	WO2006125774A1 Pediatric formulation of topiramate
11/30/2006	WO2006125762A1 Stabilized polypeptide formulations
11/30/2006	WO2006125642A1 Methods and apparatus for transdermal or transmucosal application of testosterone
11/30/2006	WO2006125620A2 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
11/30/2006	WO2006125483A1 Use of polymer mixtures for the production of coated pharmaceutical formulations and pharmaceutical formulation with mixed polymeric coating
11/30/2006	WO2006125450A1 Rectal and vaginal suppositories containing misoprostol
11/30/2006	WO2006125334A1 Cooling compounds
11/30/2006	WO2006125319A1 Bacterial management in animal holding systems
11/30/2006	WO2006125318A1 Process for treating animal waste
11/30/2006	WO2006107593A3 Matrix-based pulse release pharmaceutical formulation
11/30/2006	WO2006100567B1 Charged lipoprotein complexes and their uses
11/30/2006	WO2006100060A3 Colloidal nanocomposites comprising lbl-particles, lipids and biological components and method for the production thereof
11/30/2006	WO2006099514A3 Drug delivery compositions and related methods
11/30/2006	WO2006088894A3 Aerosol and injectable formulations of nanoparticulate benzodiazepine
11/30/2006	WO2006055603A3 Injectable nanoparticulate olanzapine formulations
11/30/2006	WO2006031420A3 Multi-layer tablets and bioadhesive dosage forms
11/30/2006	WO2006020213A3 Superabsorbent pad
11/30/2006	WO2006008517A3 Use of dry powder compositions for pulmonary delivery
11/30/2006	WO2006007095A3 High ibuprofen content granules and their preparation and use
11/30/2006	WO2005112888A3 Methods for making injectable polymer hydrogels
11/30/2006	WO2005110369A3 Sustained-release microspheres and methods of making and using same
11/30/2006	WO2005084636A3 A process for the preparation of controlled-release pharmaceutical composition of metoprolol
11/30/2006	WO2004089238A3 Dispenser having piezoelectric elements and method of operation
11/30/2006	WO2004069076A3 Oral devices and methods for controlled drug delivery
11/30/2006	US20060271022 Multi-reservoir implantable pump with variable flow rate capabilities
11/30/2006	US20060271021 Multi-reservoir implantable pump with patient controlled actuation
11/30/2006	US20060271020 Portable drug delivery device including a detachable and replaceble administration or dosing element
11/30/2006	US20060270736 Ternary and quaternary eutectic mixtures of local anesthetics substances
11/30/2006	US20060270735 Stable prostaglandin-containing compositions
11/30/2006	US20060270717 Therapeutic combination
11/30/2006	US20060270715 Dosage forms of amlodipine and processes for their preparation
11/30/2006	US20060269628 Composition for attenuation of pain or wound healing agents in dosage
11/30/2006	US20060269619 Nutrient system for individualized responsive dosing regimens
11/30/2006	US20060269613 Composition containing nanoparticles containing water-soluble basic drug encpsulated therein
11/30/2006	US20060269612 Intracellular thermal ablation using nano-particle electron spin resonance heating
11/30/2006	US20060269611 in males being treated for prostate cancer, with Toremifene or salts
11/30/2006	US20060269610 Method for producing water dispersible dry powders from poorly soluble compounds
11/30/2006	US20060269608 Pharmaceutical formulation
11/30/2006	US20060269607 Timed, sustained release systems for propranolol
11/30/2006	US20060269606 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
11/30/2006	US20060269605 Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances
11/30/2006	US20060269604 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
11/30/2006	US20060269603 Controlled release tramadol formulations
11/30/2006	US20060269602 A biocompatible, biodegradable polymer matrix, a drug and a bisphosphonate compound; increased length of time for sustained release; improved bioavailability
11/30/2006	US20060269601 Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support
11/30/2006	US20060269600 Enhancing bioavailability of oral immediate release tablets for low solubility medicants; respiratory inflammatory disorders
11/30/2006	US20060269599 Fast-dissolving pharmaceutical composition
11/30/2006	US20060269598 Antihistaminic/Decongestant/Anticholinergic Compositions and Methods of Use
11/30/2006	US20060269597 Tannate Compositions and Methods of Use for the Treatment of Respiratory Tract Conditions
11/30/2006	US20060269596 Controlled release compositions comprising an acylanilide
11/30/2006	US20060269595 Liposomal antineoplastic drugs and uses thereof
11/30/2006	US20060269594 Liposomal antineoplastic drugs and uses thereof
11/30/2006	US20060269593 Pretreatment by applying to skin; transcutaneous immunization system where the topical application of an adjuvant and an antigen or nucleic acid encoding for an antigen, to intact skin induces a systemic or mucosol antibody response
11/30/2006	US20060269589 Fragrance slurry pad
11/30/2006	US20060269584 composition for topical administration which comprises on a weight to weight basis 5% to 30% of metaflumizone, 1% to 15% of a gelling agent, 0% to 8% of a surfactant, and 45% to 80% of a non-aqueous solvent system
11/30/2006	US20060269581 Stable water in oil aminophylline emulsions
11/30/2006	US20060269578 Microemulsions and its use for preventing airway diseases
11/30/2006	US20060269542 Immunoliposome composition for targeting to a HER2 cell receptor
11/30/2006	US20060269519 Modulation of cytokine signaling regulators and applications for immunotherapy
11/30/2006	US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
11/30/2006	US20060269486 Anxiolytic agents; vaporization of thin film of diazepam
11/30/2006	US20060269475 Multi-layer structure having a predetermined layer pattern including an agent
11/30/2006	US20060266707 Drying method for macroporous polymers, and method of preparation and use of macroporous polymers made using the method
11/30/2006	DE60119082T2 Anästhetikum enthaltende formulierungen Anesthetic formulations containing
11/30/2006	DE102005024614A1 Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug Use of polymer mixtures for the production of coated dosage forms as well as with polymeric dosage form mixed coating
11/30/2006	CA2610025A1 Scopolamine for the treatment of depression and anxiety
11/30/2006	CA2609891A1 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
11/30/2006	CA2609821A1 Method of marking composition for oral administration
11/30/2006	CA2609719A1 Pediatric formulation of topiramate
11/30/2006	CA2609701A1 Compositions and methods for enhancing axon regeneration
11/30/2006	CA2609627A1 Pharmaceutical formulations useful for inhibiting acid secretion

1 ... 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 ... 2991